Rockwell Medical Inc. (RMTI) Soars 5.26% on December 12

Rockwell Medical Inc. (RMTI) Soars 5.26% on December 12

Rockwell Medical Inc. (RMTI) had a good day on the market for Wednesday December 12 as shares jumped 5.26% to close at $3.20. About 222,923 shares traded hands on 1,198 trades for the day, compared with an average daily volume of n/a shares out of a total float of 56.98 million. After opening the trading day at $3.07, shares of Rockwell Medical Inc. stayed within a range of $3.33 to $3.07.

With today’s gains, Rockwell Medical Inc. now has a market cap of $182.33 million. Shares of Rockwell Medical Inc. have been trading within a range of $6.92 and $2.88 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company’s drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.

Rockwell Medical Inc. is based out of Wixom, MI and has some 300 employees. Its CEO is Stuart Paul.

Share:
Scroll Up
error: Content is protected !!